GROUP ONE TRADING, L.P. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$2,704,749
+62.9%
53,858
+105.0%
0.01%
+80.0%
Q2 2023$1,660,580
+218.1%
26,275
+126.4%
0.01%
+150.0%
Q1 2023$522,064
+86.9%
11,604
+82.0%
0.00%
+100.0%
Q4 2022$279,333
-9.3%
6,376
+36.5%
0.00%0.0%
Q3 2022$308,000
+2269.2%
4,672
+1725.0%
0.00%
Q2 2022$13,000
-91.9%
256
-82.9%
0.00%
Q4 2021$161,000
-71.5%
1,500
-72.7%
0.00%
-100.0%
Q3 2021$565,000
+1386.8%
5,500
+1170.2%
0.00%
Q2 2021$38,000
+18.8%
433
+30.0%
0.00%
Q1 2021$32,000
-95.1%
333
-95.9%
0.00%
-100.0%
Q4 2019$654,000
+212.9%
8,167
+187.3%
0.00%
+100.0%
Q3 2019$209,000
-45.9%
2,843
-60.3%
0.00%
-33.3%
Q4 2018$386,000
+50.8%
7,158
+118.6%
0.00%
+50.0%
Q3 2018$256,000
-30.6%
3,275
-43.6%
0.00%
-33.3%
Q2 2018$369,000
+232.4%
5,809
+108.9%
0.00%
+200.0%
Q1 2017$111,000
+428.6%
2,781
+267.4%
0.00%
Q4 2016$21,000
+425.0%
757
+401.3%
0.00%
Q3 2016$4,000
-77.8%
151
-83.2%
0.00%
Q2 2016$18,000
+12.5%
9000.0%0.00%
Q1 2016$16,0009000.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders